Financhill
Sell
49

MKTX Quote, Financials, Valuation and Earnings

Last price:
$216.88
Seasonality move :
2.63%
Day range:
$216.67 - $219.17
52-week range:
$186.84 - $296.68
Dividend yield:
1.37%
P/E ratio:
29.83x
P/S ratio:
10.00x
P/B ratio:
5.89x
Volume:
797K
Avg. volume:
819.9K
1-year change:
-3.1%
Market cap:
$8.2B
Revenue:
$817.1M
EPS (TTM):
$7.27

Earnings Data

Next earnings date for MKTX
May 07
2025
Most recent earnings per share
$1.73
Beat by $0.04
(Feb 6/2025)
Consensus Estimate
$1.69
(Feb 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MKTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/07/2025 Q1 $210.1M -- -- $1.82 --
02/06/2025 Q4 $202.6M $202.4M $1.73 $1.69 $0.04
11/06/2024 Q3 $207.2M $206.7M $1.90 $1.85 $0.05
08/06/2024 Q2 $198.7M $197.7M $1.72 $1.68 $0.04
05/07/2024 Q1 $213M $210.3M $1.92 $1.88 $0.04
01/31/2024 Q4 $197.4M $197.2M $1.84 $1.72 $0.12
10/25/2023 Q3 -- -- $1.46 $1.47 -$0.01
07/20/2023 Q2 -- -- $1.59 $1.56 $0.03
04/26/2023 Q1 -- -- $1.96 $1.90 $0.06
01/25/2023 Q4 -- -- $1.58 $1.57 $0.01
10/19/2022 Q3 -- -- $1.58 $1.51 $0.07
07/20/2022 Q2 -- -- $1.78 $1.70 $0.08
04/20/2022 Q1 -- -- $1.71 $1.70 $0.01
01/26/2022 Q4 -- -- $1.37 $1.43 -$0.06
10/20/2021 Q3 -- -- $1.52 $1.44 $0.08
07/21/2021 Q2 -- -- $1.77 $1.76 $0.01
04/22/2021 Q1 -- -- $2.11 $2.14 -$0.03
01/27/2021 Q4 -- -- $1.91 $1.83 $0.08
10/28/2020 Q3 -- -- $1.78 $1.76 $0.02
07/29/2020 Q2 -- -- $2.20 $2.04 $0.16
04/29/2020 Q1 -- -- $1.96 $1.90 $0.06
01/29/2020 Q4 -- -- $1.32 $1.30 $0.02
10/23/2019 Q3 -- -- $1.42 $1.38 $0.04
07/24/2019 Q2 -- -- $1.27 $1.32 -$0.05
04/24/2019 Q1 -- -- $1.39 $1.38 $0.01
01/30/2019 Q4 -- -- $1.26 $1.16 $0.10
10/24/2018 Q3 -- -- $1.06 $0.94 $0.12
07/25/2018 Q2 -- -- $1.10 $1.05 $0.05
04/25/2018 Q1 -- -- $1.30 $1.22 $0.08
01/31/2018 Q4 -- -- $1.19 $0.88 $0.31
10/25/2017 Q3 -- -- $0.90 $0.90 --
07/26/2017 Q2 -- -- $1.00 $0.92 $0.09
04/26/2017 Q1 -- -- -- $1.00 --
01/25/2017 Q4 -- -- $0.88 $0.83 $0.05
10/26/2016 Q3 -- -- $0.82 $0.77 $0.05
07/28/2016 Q2 -- -- $0.88 $0.85 $0.03
04/27/2016 Q1 -- -- $0.77 $0.80 -$0.03
01/27/2016 Q4 -- -- $0.65 $0.63 $0.02
10/21/2015 Q3 -- -- $0.60 $0.63 -$0.03
07/22/2015 Q2 -- -- $0.64 $0.63 $0.01
04/22/2015 Q1 -- -- $0.65 $0.63 $0.02

MarketAxess Holdings Earnings Questions

  • How Much did MarketAxess Holdings Generate in Revenue Last Quarter?

    MarketAxess Holdings reported $202.4M worth of top line sales in its most recent quarter.

  • Did MarketAxess Holdings Beat Earnings Last Quarter?

    MarketAxess Holdings announced earnings per share of $1.73 which represents a beat of analyst forecast a $1.69 per share.

  • Is MarketAxess Holdings Profitable?

    MarketAxess Holdings reported $138.6M that represents $3.69 per share over the last quarter.

  • What is the Analyst Consensus for MarketAxess Holdings EPS Next Year?

    MarketAxess Holdings's earnings are forecast to grow from $7.28 per share to $7.22 per share next year representing an increase of 4.28%.

  • When is MarketAxess Holdings's Earnings Date?

    MarketAxess Holdings's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock